Australia markets closed

Navidea Biopharmaceuticals, Inc. (NO1A.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.06650.0000 (0.00%)
At close: 09:33AM CEST
Show:
Income statement
Cash flow
Annual

Balance sheet

Currency in USD. All numbers in thousands
Breakdown
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
1,996
4,231
2,670
1,047
Other short-term investments
-
-
-
0
Total cash
1,996
4,231
2,670
1,047
Net receivables
0.61
1.021
58.754
0
Inventory
427.344
151.155
169.798
0
Other current assets
780.11
908.273
700.716
967.285
Total current assets
3,204
5,383
6,528
2,916
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
943.088
1,315
1,304
1,612
Accumulated depreciation
-787.441
-1,067
-921.402
-1,300
Net property, plant and equipment
155.647
248.705
382.257
311.898
Intangible assets
1,000
785.651
620.241
385.413
Other long-term assets
11.774
227.192
227.192
537.812
Total non-current assets
1,168
1,262
1,230
1,235
Total assets
4,372
6,645
7,758
4,151
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
543.613
453.427
745.443
305.955
Accounts payable
2,123
1,421
1,162
1,112
Accrued liabilities
5,667
1,914
1,726
1,212
Deferred revenues
800
40.825
-
-
Other current liabilities
1.621
0.04
31.634
13.618
Total current liabilities
9,942
5,300
4,715
3,820
Non-current liabilities
Long-term debt
1,872
-
-
-
Deferred revenues
700
700
700
700
Total non-current liabilities
2,573
720.288
996.006
1,212
Total liabilities
12,515
6,020
5,711
5,032
Stockholders' equity
Common stock
223.697
221.349
218.278
210.232
Retained earnings
-388,003
-370,788
-359,057
-347,671
Accumulated other comprehensive income
-
-
-
0
Total stockholders' equity
-8,436
-106.556
1,316
-1,612
Total liabilities and stockholders' equity
4,372
6,645
7,758
4,151